A phase II trial with D-Trp-6 (decapeptyl) in premenopausal RH+, hormonal untreated advanced breast cancer patients

1993 ◽  
Vol 29 ◽  
pp. S86
Author(s):  
E. Garcia-Giralt ◽  
P. Beuzeboc ◽  
T. Dorval ◽  
M. Jouve ◽  
A. Livartowski ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Breast Cancer Patients

A Phase II Clinical Trial of Flutamide in the Treatment of Advanced Breast Cancer

1988 ◽  
Vol 74 (1) ◽  
pp. 53-56 ◽  
Author(s):  
Tiping Zhao ◽  
Guifen He
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Advanced Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Transient Response ◽  
Postmenopausal Breast Cancer ◽  
Phase Ii Clinical Trial ◽  
Advanced Breast ◽  
Breast Cancer Patients

An antiandrogenic agent flutamide was used in the treatment of one male and 14 female postmenopausal breast cancer patients. Only a mild and transient response was seen in 2 female patients. Therefore, flutamide cannot be used solely in the treatment of female postmenopausal breast cancer.

Phase II study of divided-dose vinblastine in advanced breast cancer patients

1988 ◽  
Vol 21 (1) ◽  
Author(s):  
Giuseppe Giaccone ◽  
Matteo Bagatella ◽  
Oscar Bertetto ◽  
Michela Donadio ◽  
Alessandro Calciati
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Divided Dose ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Breast Cancer Patients

Paclitaxel and liposomal doxorubicin (Caelyx) combination in advanced breast cancer patients: a Phase II study

2003 ◽  
Author(s):  
Sotiris Rigatos ◽  
Dimitrios Tsavdaridis ◽  
Athanasios Athanasiadis ◽  
John Stathopoulos ◽  
George Stathopoulos
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Breast Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document